PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1684343
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1684343
Endoscopic Ultrasonography Market size was valued at US$ 1,490.32 Million in 2024, expanding at a CAGR of 6.99% from 2025 to 2032.
The Endoscopic Ultrasonography (EUS) market revolves around the use of high-frequency ultrasound imaging combined with endoscopy to visualize internal organs and tissues, primarily in gastroenterology, pulmonology, and oncology applications. Increasing prevalence of gastrointestinal cancers and pancreatic disorders, along with advancements in minimally invasive procedures, has led to a rise in EUS adoption, with over 70% of gastroenterologists incorporating the technique for early-stage cancer detection. Technological innovations such as elastography and contrast-enhanced EUS have further improved diagnostic accuracy. However, the high cost of EUS systems, averaging between $80,000 and $250,000 per unit, along with a shortage of skilled professionals, poses challenges to market expansion. Emerging opportunities lie in AI-powered image analysis and the integration of EUS with robotic-assisted procedures, which could enhance precision and reduce operator dependency. The increasing number of ambulatory surgical centers worldwide is also expanding access to EUS, particularly in regions with improving healthcare infrastructure.
Endoscopic Ultrasonography Market- Market Dynamics
Rising Adoption of Minimally Invasive Diagnostic Techniques
The growing preference for minimally invasive diagnostic techniques has significantly boosted the adoption of Endoscopic Ultrasonography (EUS), particularly in gastroenterology and oncology. According to the American Cancer Society, over 64,000 new cases of pancreatic cancer are diagnosed annually in the U.S., increasing the demand for early detection methods like EUS. Additionally, a study published by the National Institutes of Health (NIH) highlighted that EUS-guided fine-needle aspiration (FNA) achieves an accuracy rate exceeding 85% for diagnosing pancreatic cysts, reducing the need for more invasive procedures. Major hospitals, including Mayo Clinic and Cleveland Clinic, have expanded EUS capabilities, incorporating contrast-enhanced imaging and elastography for more precise diagnostics. As more healthcare facilities adopt these advanced techniques, the market is expected to witness sustained growth, particularly in developed nations with robust healthcare infrastructure.
Endoscopic Ultrasonography Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.99% over the forecast period (2025-2032)
Based on product type segmentation, Endoscopes were predicted to show maximum market share in the year 2024
Based on Technology segmentation, Linear scanning was the leading Technology in 2024
Based on Application segmentation, Oncology was the leading Application in 2024
On the basis of region, North America was the leading revenue generator in 2024
The Global Endoscopic Ultrasonography Market is segmented on the basis of Product Type, Technology, Application, End-User, and Region.
The market is divided into six categories based on product type: Endoscopes, Ultrasound Probes, Ultrasound Processors, Needles, Accessories, and Imaging Systems. Endoscopes hold the highest priority as they are essential for EUS procedures, followed by ultrasound processors that enhance imaging precision. Ultrasound probes rank next, enabling real-time visualization. Needles are crucial for biopsies, while imaging systems and accessories support procedural efficiency and workflow.
The market is divided into five categories based on Technology: Radial Scanning, Linear Scanning, Elastography, Contrast-Enhanced EUS, and Fine-Needle Aspiration (FNA). Linear scanning holds the highest priority due to its versatility in both diagnostic and interventional procedures, followed by radial scanning for detailed imaging. Fine-Needle Aspiration (FNA) is crucial for biopsies, while contrast-enhanced EUS and elastography improve accuracy in tissue characterization and cancer detection.
Endoscopic Ultrasonography Market- Geographical Insights
The Endoscopic Ultrasonography (EUS) market exhibits significant regional variations, with North America and Europe leading due to well-established healthcare infrastructure and high adoption rates of advanced diagnostic technologies. The United States, backed by organizations like the American Society for Gastrointestinal Endoscopy (ASGE), sees widespread integration of EUS in hospitals and specialized clinics, with over 1.6 million endoscopic ultrasound procedures performed annually. In Europe, countries such as Germany, France, and the UK benefit from strong reimbursement policies and increasing investments in early cancer detection. Meanwhile, Asia-Pacific is emerging as a high-growth region, driven by rising gastrointestinal cancer cases in China, Japan, and India, along with government initiatives to improve access to minimally invasive diagnostics. For instance, Japan's National Cancer Center actively promotes advanced imaging techniques, increasing EUS penetration. Latin America and the Middle East & Africa show steady growth, although cost barriers and limited skilled professionals hinder widespread adoption. However, improving healthcare infrastructure and medical tourism in these regions present lucrative opportunities for future market expansion.
The Endoscopic Ultrasonography (EUS) market is highly competitive, with key players focusing on technological advancements, strategic partnerships, and geographic expansion to strengthen their market presence. Leading companies such as Olympus Corporation, Fujifilm Holdings, and Pentax Medical (HOYA Corporation) dominate the market, offering a range of advanced EUS systems integrated with high-resolution imaging and elastography capabilities. Olympus, for instance, holds a significant share with its EU-ME3 ultrasound processor, enhancing diagnostic precision. Boston Scientific is actively investing in EUS-guided therapeutic applications, such as EUS-guided biliary drainage, expanding the technology's clinical scope. Emerging players, including SonoScape and Medi-Globe, are entering the market with cost-effective EUS solutions to cater to price-sensitive regions. Strategic collaborations are also shaping the competitive landscape, with major companies partnering with research institutions to develop AI-powered EUS imaging. Additionally, regulatory approvals, such as the FDA clearance for novel EUS-guided biopsy devices, are accelerating innovation. As competition intensifies, differentiation through technological innovation and service excellence remains key to market leadership.
In February 2024, FUJIFILM India launched the ALOKA ARIETTA 850, an advanced endoscopic ultrasound system, at Fortis Hospital, Bengaluru. This system enhances diagnostic precision for gastrointestinal diseases, enabling targeted treatments like pancreatic cyst drainage without surgery. It improves cancer staging and offers clearer imaging with innovative features.
In January 2024, Canon Medical and Olympus announced a business alliance to collaborate on Endoscopic Ultrasound Systems. Canon Medical will develop and manufacture diagnostic ultrasound systems, while Olympus will handle sales and marketing. The collaboration aims to provide advanced EUS equipment with high-quality image diagnoses, starting in Japan and Europe.
In May 2024, Cook Medical launched the EchoTip AcuCore(TM) EUS Biopsy Needle in the US. This 22-gauge needle, used with an ultrasound endoscope, enables precise fine needle biopsies of gastrointestinal lesions. It features a Franseen tip for controlled tissue puncture and a flexible, spring-coiled sheath for accessing difficult anatomy.